A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia

por Kay, Neil E., Strati, Paolo, LaPlant, Betsy R., Leis, Jose F., Nikcevich, Daniel, Call, Timothy G., Pettinger, Adam M., Lesnick, Connie E., Hanson, Curtis A., Shanafelt, Tait D.
Publicado 2016

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease

por McKeon, Andrew, Lesnick, Connie, Vorasoot, Nisa, Buckley, Monica W., Dasari, Surendra, Flanagan, Eoin P., Gilligan, Michael, Lafrance-Corey, Reghann, Miske, Ramona, Pittock, Sean J., Scharf, Madeleine, Yang, Binxia, Zekeridou, Anastasia, Dubey, Divyanshu, Mills, John
Publicado 2023

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance

por Sinha, Sutapa, Secreto, Charla R., Boysen, Justin C., Lesnick, Connie, Wang, Zhiquan, Ding, Wei, Call, Timothy G., Kenderian, Saad J., Parikh, Sameer A., Warner, Steven L., Bearss, David J., Ghosh, Asish K., Kay, Neil E.
Publicado 2021

Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis

por Boddicker, Nicholas J., Achenbach, Sara J., Parikh, Sameer A., Kleinstern, Geffen, Braggio, Esteban, Norman, Aaron D., Rabe, Kari G., Vachon, Celine M., Lesnick, Connie E., Call, Timothy G., Olson, Janet E., Cerhan, James R., Kay, Neil E., Hanson, Curtis A., Shanafelt, Tait D., Slager, Susan L.
Publicado 2022

Progression and survival of MBL: a screening study of 10 139 individuals

por Slager, Susan L., Parikh, Sameer A., Achenbach, Sara J., Norman, Aaron D., Rabe, Kari G., Boddicker, Nicholas J., Olson, Janet E., Kleinstern, Geffen, Lesnick, Connie E., Call, Timothy G., Cerhan, James R., Vachon, Celine M., Kay, Neil E., Braggio, Esteban, Hanson, Curtis A., Shanafelt, Tait D.
Publicado 2022

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

por Parikh, Sameer A., Rabe, Kari G., Kay, Neil E., Call, Timothy G., Ding, Wei, Leis, Jose F., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Koehler, Amber B., Schwager, Susan M., Lesnick, Connie E., Kleinstern, Geffen, Van Dyke, Daniel, Hanson, Curtis A., Braggio, Esteban, Slager, Susan L., Shanafelt, Tait D.
Publicado 2021

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

por Kleinstern, Geffen, Weinberg, J. Brice, Parikh, Sameer A., Braggio, Esteban, Achenbach, Sara J., Robinson, Dennis P., Norman, Aaron D., Rabe, Kari G., Boddicker, Nicholas J., Vachon, Celine M., Lesnick, Connie E., Call, Timothy G., Brander, Danielle M., Rassenti, Laura Z., Kipps, Thomas J., Olson, Janet E., Cerhan, James R., Kay, Neil E., Furman, Richard R., Hanson, Curtis A., Shanafelt, Tait D., Slager, Susan L.
Publicado 2021